Gerd Kochendoerfer - Jan 2, 2025 Form 4 Insider Report for ATAI Life Sciences N.V. (ATAI)

Role
Chief Operating Officer
Signature
/s/ Ryan Barrett, Attorney-in-fact
Stock symbol
ATAI
Transactions as of
Jan 2, 2025
Transactions value $
$0
Form type
4
Date filed
1/3/2025, 04:30 PM
Previous filing
Dec 13, 2024

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ATAI Stock Option Award $0 +1.45M $0.00 1.45M Jan 2, 2025 Common Shares 1.45M $1.60 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The stock option shall vest as to 25% on December 3, 2025 and in 36 substantially equal monthly installments thereafter.